CG Oncology is well-positioned to enter a de-risked NMIBC market with cretostimogene. Click here to read why CGON stock is a ...
The regulatory clearance brings Coreline Soft’s total to 13 FDA 510(k) clearances and broadens its chest AI portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results